EDGE THERAPEUTICS INC's ticker is EDGE and the CUSIP is 279870109. A total of 55 filers reported holding EDGE THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $8,844,000 | -34.2% | 943,906 | -24.7% | 1.67% | -30.7% |
Q3 2017 | $13,449,000 | -12.9% | 1,253,394 | -16.7% | 2.41% | -44.2% |
Q2 2017 | $15,437,000 | +25.4% | 1,504,612 | +11.3% | 4.32% | +48.0% |
Q1 2017 | $12,312,000 | -5.3% | 1,351,516 | +29.9% | 2.92% | -39.6% |
Q4 2016 | $13,003,000 | +77.7% | 1,040,265 | +48.0% | 4.84% | +75.9% |
Q3 2016 | $7,318,000 | +36.6% | 703,000 | +32.6% | 2.75% | +6.7% |
Q2 2016 | $5,358,000 | +52.0% | 530,000 | +37.6% | 2.58% | +30.6% |
Q1 2016 | $3,524,000 | +77.5% | 385,100 | +142.5% | 1.97% | +107.7% |
Q4 2015 | $1,985,000 | – | 158,807 | – | 0.95% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |